Cargando…
Lack of partial renal response by 12 weeks after induction therapy predicts poor renal response and systemic damage accrual in lupus nephritis class III or IV
BACKGROUND: Lupus nephritis class III or IV is associated with a poor prognosis for both patient and renal survival. Recommendations for the management of lupus nephritis have recently been established, and changing therapies is recommended for patients who do not respond adequately to induction the...
Autores principales: | Hanaoka, Hironari, Yamada, Hidehiro, Kiyokawa, Tomofumi, Iida, Harunobu, Suzuki, Takeshi, Yamasaki, Yoshioki, Ooka, Seido, Nagafuchi, Hiroko, Okazaki, Takahiro, Ichikawa, Daisuke, Shirai, Sayuri, Shibagaki, Yugo, Koike, Junki, Ozaki, Shoichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237142/ https://www.ncbi.nlm.nih.gov/pubmed/28086993 http://dx.doi.org/10.1186/s13075-016-1202-z |
Ejemplares similares
-
Comparison of renal response to four different induction therapies in Japanese patients with lupus nephritis class III or IV: A single-centre retrospective study
por: Hanaoka, Hironari, et al.
Publicado: (2017) -
Renal protective effect of antiplatelet therapy in antiphospholipid antibody-positive lupus nephritis patients without antiphospholipid syndrome
por: Hanaoka, Hironari, et al.
Publicado: (2018) -
Rhabdomyolysis in a Patient with Polyarteritis Nodosa
por: Iida, Harunobu, et al.
Publicado: (2017) -
Early achievement of deep remission predicts low incidence of renal flare in lupus nephritis class III or IV
por: Hanaoka, Hironari, et al.
Publicado: (2018) -
Hydroxychloroquine Improves the Disease Activity and Allows the Reduction of the Corticosteroid Dose Regardless of Background Treatment in Japanese Patients with Systemic Lupus Erythematosus
por: Hanaoka, Hironari, et al.
Publicado: (2019)